A detailed history of State Board Of Administration Of Florida Retirement System transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, State Board Of Administration Of Florida Retirement System holds 28,800 shares of MRSN stock, worth $46,656. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,800
Previous 28,800 -0.0%
Holding current value
$46,656
Previous $57,000 5.26%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$2.0 - $4.45 $2,796 - $6,221
1,398 Added 5.1%
28,800 $57,000
Q1 2024

May 08, 2024

SELL
$2.16 - $5.94 $3,019 - $8,304
-1,398 Reduced 4.85%
27,402 $122,000
Q4 2023

Feb 09, 2024

BUY
$1.11 - $2.34 $31,968 - $67,392
28,800 New
28,800 $66,000
Q2 2023

Aug 11, 2023

BUY
$3.08 - $9.55 $3,326 - $10,314
1,080 Added 3.94%
28,482 $93,000
Q4 2022

Feb 07, 2023

BUY
$5.65 - $7.86 $621 - $864
110 Added 0.4%
27,402 $161,000
Q2 2022

Aug 05, 2022

BUY
$2.84 - $5.0 $28 - $50
10 Added 0.04%
27,292 $126,000
Q4 2021

Feb 08, 2022

BUY
$5.48 - $9.86 $904 - $1,626
165 Added 0.61%
27,282 $170,000
Q2 2021

Aug 10, 2021

BUY
$13.28 - $18.07 $63,172 - $85,958
4,757 Added 21.27%
27,117 $368,000
Q1 2021

May 10, 2021

SELL
$15.31 - $26.52 $10,410 - $18,033
-680 Reduced 2.95%
22,360 $362,000
Q4 2020

Feb 08, 2021

SELL
$16.84 - $27.59 $12,461 - $20,416
-740 Reduced 3.11%
23,040 $613,000
Q3 2020

Nov 09, 2020

BUY
$16.2 - $25.7 $67,392 - $106,912
4,160 Added 21.2%
23,780 $443,000
Q2 2020

Aug 07, 2020

BUY
$5.24 - $23.4 $102,808 - $459,108
19,620 New
19,620 $459,000

Others Institutions Holding MRSN

About Mersana Therapeutics, Inc.


  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $157M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.